This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Achiron, A. Articles by Melamed, E. Search for Related Content PubMed PubMed Citation Articles by Achiron, A. Articles by Melamed, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 6-AMINOCAPROIC ACID Medline Plus Health Information Vaginal Bleeding

Stroke, Vol 21, 817-819, Copyright © 1990 by American Heart Association

ARTICLES

Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia

A Achiron, M Gornish and E Melamed
Department of Neurology, Beilinson Medical Center, Petach-Tiqva, Israel.

We describe a 42-year-old woman who developed superior sagittal and left transverse sinus thrombosis associated with prolonged epsilon- aminocaproic acid therapy for menorrhagia. This antifibrinolytic agent has been used in women with menorrhagia to promote clotting and reduce blood loss. Although increased risk of thromboembolic disease has been reported during treatment with epsilon-aminocaproic acid, cerebral sinus thrombosis has not been previously described. Careful use of epsilon-aminocaproic acid therapy is recommended.